US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

The package revives President Donald Trump’s much-maligned Most Favored Nation rule but goes further into the private markets and beyond, leveraging the patent system, drug importation and more.

A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...

INDIANAPOLIS — Eli Lilly's stock wobbled ... able to switch to Wegovy if the Lilly drug is excluded from their coverage, Whitrap said. CVS Health also said Thursday that it will start selling Wegovy ...

AHA comments on the Centers for Medicare & Medicaid Services information collection request regarding the Medicare Transaction Facilitator (MTF) under the Medicare drug negotiation program.

Thu, 01 May, 2025 - 20:31 Eli Lilly posted better-than-expected ... Zepbound posted sales of $2.31bn for the first quarter. Lilly said lower prices for the drug impacted revenue, but demand ...